STOCK TITAN

Brian Rosen, Commercial Strategy Senior Executive, Appointed as Director of Capstone Companies, Inc.

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
management

Capstone Companies (OTCQB: CAPC) has appointed Brian Rosen as a non-employee director, effective January 20, 2025. Rosen brings extensive experience in marketing, business development, contract negotiation, and government relations, having served in senior roles at Novavax and the Leukemia & Lymphoma Society.

The appointment aligns with CAPC's strategic shift following the discontinuation of its LED and Smart Mirror consumer products division. The company, currently generating no revenue, is actively seeking to establish new business lines through internal development, merger, acquisition, or a combination thereof. The addition of Rosen, with his background in pursuing revenue-generating opportunities, is part of CAPC's broader initiative to develop year-round social, fitness, and health programs and facilities.

Capstone Companies (OTCQB: CAPC) ha nominato Brian Rosen come direttore non dipendente, con effetto dal 20 gennaio 2025. Rosen porta con sé una vasta esperienza nel marketing, nello sviluppo commerciale, nella negoziazione di contratti e nelle relazioni governative, avendo ricoperto ruoli di alto livello presso Novavax e la Leukemia & Lymphoma Society.

La nomina si allinea con il cambiamento strategico di CAPC dopo la cessazione della divisione dei prodotti per consumatori LED e Smart Mirror. Attualmente, l'azienda non genera ricavi e sta attivamente cercando di stabilire nuove linee di business attraverso lo sviluppo interno, fusioni, acquisizioni o una combinazione di questi. L'aggiunta di Rosen, con il suo background nella ricerca di opportunità generatrici di entrate, è parte dell'iniziativa più ampia di CAPC per sviluppare programmi e strutture sociali, fitness e salute durante tutto l'anno.

Capstone Companies (OTCQB: CAPC) ha nombrado a Brian Rosen como director no empleado, con efecto a partir del 20 de enero de 2025. Rosen aporta una amplia experiencia en marketing, desarrollo de negocios, negociación de contratos y relaciones gubernamentales, habiendo ocupado cargos de alto nivel en Novavax y la Sociedad de Leucemia y Linfoma.

El nombramiento está alineado con el cambio estratégico de CAPC tras la eliminación de su división de productos para consumidores LED y Espejos Inteligentes. La empresa, que actualmente no genera ingresos, está buscando activamente establecer nuevas líneas de negocio a través del desarrollo interno, fusiones, adquisiciones o una combinación de estos. La incorporación de Rosen, con su experiencia en la búsqueda de oportunidades generadoras de ingresos, forma parte de la iniciativa más amplia de CAPC para desarrollar programas y instalaciones sociales, de fitness y de salud durante todo el año.

Capstone Companies (OTCQB: CAPC)는 2025년 1월 20일부터 비상근 이사로 Brian Rosen을 임명했습니다. Rosen은 Novavax와 Leukemia & Lymphoma Society에서 고위직을 역임하며 마케팅, 비즈니스 개발, 계약 협상 및 정부 관계에서 폭넓은 경험을 쌓았습니다.

이번 임명은 CAPC가 LED 및 스마트 미러 소비자 제품 부서를 중단한 후의 전략적 전환과 일치합니다. 현재 수익을 창출하지 않는 이 회사는 내부 개발, 인수 합병 또는 이 둘의 조합을 통해 새로운 비즈니스 라인을 확립하기 위해 적극적으로 노력하고 있습니다. 수익 창출 기회를 추구한 경험이 있는 Rosen의 합류는 CAPC가 연중 사회, 피트니스 및 건강 프로그램과 시설을 개발하기 위한 더 넓은 계획의 일환입니다.

Capstone Companies (OTCQB: CAPC) a nommé Brian Rosen comme directeur non salarié, avec effet au 20 janvier 2025. Rosen possède une vaste expérience en marketing, développement commercial, négociation de contrats et relations gouvernementales, ayant occupé des postes de direction chez Novavax et la Leukemia & Lymphoma Society.

Cette nomination s'inscrit dans le cadre du changement stratégique de CAPC suite à l'arrêt de sa division de produits consommateur LED et Miroirs Intelligents. Actuellement, l'entreprise ne génère aucun revenu et cherche activement à établir de nouvelles lignes commerciales par le développement interne, des fusions, des acquisitions ou une combinaison de ces options. L'ajout de Rosen, avec son expérience dans la recherche d'opportunités génératrices de revenus, fait partie d'une initiative plus large de CAPC visant à développer des programmes sociaux, de remise en forme et de santé tout au long de l'année.

Capstone Companies (OTCQB: CAPC) hat Brian Rosen mit Wirkung zum 20. Januar 2025 als nicht-vergüteten Direktor ernannt. Rosen bringt umfassende Erfahrung in den Bereichen Marketing, Geschäftsentwicklung, Vertragsverhandlungen und Regierungsbeziehungen mit, nachdem er leitende Positionen bei Novavax und der Leukemia & Lymphoma Society inne hatte.

Die Ernennung steht im Einklang mit CAPCs strategischer Neuausrichtung nach der Einstellung seiner Verbraucherprodukte-Division für LED und Smart Mirror. Das Unternehmen, das derzeit keine Einnahmen generiert, sucht aktiv nach neuen Geschäftsfeldern durch interne Entwicklung, Fusionen, Übernahmen oder eine Kombination davon. Die Hinzufügung von Rosen, der über einen Hintergrund in der Verfolgung von ertragsgenerierenden Möglichkeiten verfügt, ist Teil von CAPCs umfassenderer Initiative, ganzjährige soziale, Fitness- und Gesundheitsprogramme sowie -einrichtungen zu entwickeln.

Positive
  • Strategic appointment of experienced executive with proven track record in business development
  • Company actively pursuing new revenue streams and business opportunities
  • Clear strategic direction towards social, fitness, and health programs
Negative
  • Company currently generates no revenue
  • Previous LED and Smart Mirror consumer products operations discontinued due to declining sales
  • Significant business transformation required to establish new revenue streams

DEERFIELD BEACH, Fla.--(BUSINESS WIRE)-- Capstone Companies, Inc. (OTCQB: CAPC) announced today the appointment of Brian Rosen as a non-employee director, effective January 20, 2025.

Mr. Rosen has extensive experience in marketing, business development, contract negotiation and government relations as well as experience as a member of two public companies’ management. He served as Senior Vice President, Global Market Access, Public Policy & Alliances (2021 - 2023), Senior Vice President, Commercial Strategy (2018 - 2021) and Vice President, Market Access, Policy, & Government Affairs (2015 - 2017) with Novavax, Inc. (NASDAQ: NVAX). Before Novavax, Inc., Mr. Rosen served as Chief Policy, Advocacy & Patient Services Officer (2014 - 2015), Senior Vice President, Public Policy (2013 - 2014) and Vice President, Legislative and Regulatory Affairs (2012 - 2013) for the Leukemia & Lymphoma Society, Washington, D.C. He also has a J.D. degree from Hofstra University School of Law.

“Brian is skilled at pursuing new business opportunities and developing resulting revenue streams and in negotiating contracts. He has a record of accomplishment in the pursuit of revenue generating opportunities. I believe his skills, coupled with government relations and public company experience, will prove valuable to Capstone Companies’ efforts to establish a new business line and pursue a growth strategy for year-round social, fitness and health programs and facilities,” said Stewart Wallach, Chair of the Company’s Board of Directors.

About Capstone Companies, Inc. Capstone Companies, Inc. is an SEC reporting company with its common stock quoted on OTC QB market. Formerly engaged in producing LED and Smart Mirror consumer products, Company ended its consumer product operations due to declining sales and has been seeking to establish a new business line and revenue generating operations through internal development, merger, acquisition or a combination of those actions. The Company currently has no revenue generating operations. The appointment of a new CEO and appointment of directors is part of the Company’s efforts to establish revenue generating operations by bringing in new management members with experience in industries other than the Company’s former industry as well as a proven ability to build, arrange funding or assist in creating sustainable, new business lines.

FORWARD LOOKING STATEMENTS. Except for statements of historical fact in this press release, the information contained above contains forward-looking statements, which statements are characterized by words like “should,” “may,” “intend,” “expect,” “hope,” “believe,” “anticipate” and similar words. Forward looking statements are not guarantees of future performance and undue reliance should not be placed on them. Forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any statements about future performance or results expressed or implied by such forward-looking statements. Capstone Companies, Inc. (“Company”) is a public shell company without revenue generating revenues and relies on working capital funding from third parties to sustain its corporate existence and fund the compliance requirements as an SEC reporting company with its stock quoted on the OTC QB Venture Market. The Company is also a “penny stock” company with limited public market liquidity and no primary market makers. As such, Company may be unable to develop a new business line, or acquire or merge with an existing operating company, or, even if a new business line or revenue generating operation is established, to fund and successfully operate that new business line or operation. The capabilities or prior performance or contributions of any officer or director with other companies is not to be taken as indicative of his or her performance or contributions as an officer or director of the Company. Further, the public auditors of the Company have expressed doubt as to the Company as a going concern. Company may be unable to obtain adequate, affordable and timely funding to sustain any new business line or existing operations. There is substantial doubt about the Company’s ability to establish a new business line or sustain an operation. There is no existing agreement by the Company and a third party for a merger or acquisition of a company or assets. Any investment in the common stock of the Company is a highly risky investment that is not suitable for investors who cannot afford the total loss of the investment and the inability to liquidate the investment. The risk factors in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and other filings with the SEC should be carefully considered prior to any investment decision. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.

CONTACT information and media inquiries:

irinquiries@capstonecompaniesinc.com

Telephone: (954) 570-8889, ext. 315

Source: Capstone Companies, Inc.

FAQ

When will Brian Rosen join Capstone Companies (CAPC) as director?

Brian Rosen will join Capstone Companies (CAPC) as a non-employee director effective January 20, 2025.

Why did Capstone Companies (CAPC) discontinue its LED and Smart Mirror products?

CAPC discontinued its LED and Smart Mirror consumer products operations due to declining sales.

What is Capstone Companies' (CAPC) new business strategy?

CAPC is seeking to establish new revenue-generating operations through internal development, merger, acquisition, or a combination of these actions, focusing on year-round social, fitness, and health programs and facilities.

What is Brian Rosen's professional background before joining CAPC?

Brian Rosen previously served in senior roles at Novavax, including Senior VP of Global Market Access and Commercial Strategy, and held executive positions at the Leukemia & Lymphoma Society.

Novavax Inc

NASDAQ:NVAX

NVAX Rankings

NVAX Latest News

NVAX Stock Data

1.44B
153.14M
4.4%
59.99%
24.45%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
GAITHERSBURG